Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 4.67
(-0.21%)
CNY 4.67
(-0.21%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -43.99 Million CNY | -61.59% |
| 2022 | 508.56 Million CNY | 26.78% |
| 2021 | 447.84 Million CNY | -32.66% |
| 2020 | 682.56 Million CNY | -40.99% |
| 2019 | 1.07 Billion CNY | 20.47% |
| 2018 | 939.3 Million CNY | 49.07% |
| 2017 | 681.89 Million CNY | -0.14% |
| 2016 | 583.7 Million CNY | -24.21% |
| 2015 | 823.82 Million CNY | 245.97% |
| 2014 | 243.49 Million CNY | 209.23% |
| 2013 | 28.95 Million CNY | -35.64% |
| 2012 | 116.11 Million CNY | -37.55% |
| 2011 | 195 Million CNY | 12.65% |
| 2010 | 160.66 Million CNY | 65.08% |
| 2009 | 98.25 Million CNY | 11.78% |
| 2008 | 91.92 Million CNY | -5.74% |
| 2007 | 97.66 Million CNY | -11.14% |
| 2006 | 112.57 Million CNY | 10.39% |
| 2005 | 101.91 Million CNY | 37.38% |
| 2004 | 74.18 Million CNY | 60.84% |
| 2003 | 46.12 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 12.41 Million CNY | -75.95% |
| 2024 Q3 | -29.14 Million CNY | -191.47% |
| 2024 Q1 | 88.01 Million CNY | 142.37% |
| 2023 Q2 | -9.68 Million CNY | -145.5% |
| 2023 Q1 | 21.28 Million CNY | 130.45% |
| 2023 Q4 | -138.03 Million CNY | -734.37% |
| 2023 FY | - CNY | -61.59% |
| 2023 Q3 | -16.54 Million CNY | -70.86% |
| 2022 Q3 | 84.52 Million CNY | -26.21% |
| 2022 Q1 | 111.21 Million CNY | 78.44% |
| 2022 FY | - CNY | 26.78% |
| 2022 Q4 | -69.9 Million CNY | -182.7% |
| 2022 Q2 | 114.54 Million CNY | 2.99% |
| 2021 Q4 | 62.32 Million CNY | 175.95% |
| 2021 FY | - CNY | -32.66% |
| 2021 Q1 | 83.17 Million CNY | 397.89% |
| 2021 Q2 | -7.27 Million CNY | -108.74% |
| 2021 Q3 | 22.58 Million CNY | 410.55% |
| 2020 Q1 | 130.19 Million CNY | 24.12% |
| 2020 Q2 | 200.08 Million CNY | 53.68% |
| 2020 Q3 | 116.72 Million CNY | -41.66% |
| 2020 FY | - CNY | -40.99% |
| 2020 Q4 | -27.91 Million CNY | -123.92% |
| 2019 Q1 | 250.55 Million CNY | 51.33% |
| 2019 FY | - CNY | 20.47% |
| 2019 Q4 | 104.89 Million CNY | -55.74% |
| 2019 Q3 | 236.98 Million CNY | -32.19% |
| 2019 Q2 | 349.51 Million CNY | 39.49% |
| 2018 Q1 | 141.81 Million CNY | 398.88% |
| 2018 FY | - CNY | 49.07% |
| 2018 Q4 | 165.56 Million CNY | -32.5% |
| 2018 Q3 | 245.3 Million CNY | 16.57% |
| 2018 Q2 | 210.42 Million CNY | 48.38% |
| 2017 Q2 | 163.52 Million CNY | 10.19% |
| 2017 Q3 | 83.8 Million CNY | -48.75% |
| 2017 Q1 | 148.4 Million CNY | 440.19% |
| 2017 FY | - CNY | -0.14% |
| 2017 Q4 | 28.42 Million CNY | -66.08% |
| 2016 Q3 | 150.63 Million CNY | -26.11% |
| 2016 Q1 | 174.39 Million CNY | 38.38% |
| 2016 FY | - CNY | -24.21% |
| 2016 Q4 | -43.62 Million CNY | -128.96% |
| 2016 Q2 | 203.86 Million CNY | 16.9% |
| 2015 FY | - CNY | 245.97% |
| 2015 Q4 | 126.03 Million CNY | -8.16% |
| 2015 Q3 | 137.22 Million CNY | -36.4% |
| 2015 Q2 | 215.75 Million CNY | 12.32% |
| 2015 Q1 | 192.09 Million CNY | 184.24% |
| 2014 FY | - CNY | 209.23% |
| 2014 Q3 | 15.06 Million CNY | -36.46% |
| 2014 Q2 | 23.71 Million CNY | 59.08% |
| 2014 Q4 | 67.58 Million CNY | 348.48% |
| 2014 Q1 | 14.9 Million CNY | 262.68% |
| 2013 Q1 | 11.32 Million CNY | 161.31% |
| 2013 Q2 | 6.21 Million CNY | -45.11% |
| 2013 Q3 | -13 Million CNY | -309.09% |
| 2013 Q4 | -9.16 Million CNY | 29.51% |
| 2013 FY | - CNY | -35.64% |
| 2012 Q4 | -18.47 Million CNY | -359.63% |
| 2012 Q3 | -4.01 Million CNY | -113.03% |
| 2012 FY | - CNY | -37.55% |
| 2012 Q1 | 53.29 Million CNY | 75.05% |
| 2012 Q2 | 30.84 Million CNY | -42.14% |
| 2011 FY | - CNY | 12.65% |
| 2011 Q4 | 30.44 Million CNY | -8.34% |
| 2011 Q3 | 33.21 Million CNY | -2.74% |
| 2011 Q2 | 34.15 Million CNY | -22.99% |
| 2011 Q1 | 44.35 Million CNY | 397.11% |
| 2010 Q1 | 27.25 Million CNY | 2.53% |
| 2010 Q3 | 34.86 Million CNY | -35.03% |
| 2010 Q2 | 53.65 Million CNY | 96.88% |
| 2010 FY | - CNY | 65.08% |
| 2010 Q4 | 8.92 Million CNY | -74.41% |
| 2009 FY | - CNY | 11.78% |
| 2009 Q4 | 26.58 Million CNY | 224.1% |
| 2009 Q3 | 8.2 Million CNY | -52.4% |
| 2009 Q2 | 17.22 Million CNY | 80.07% |
| 2009 Q1 | 9.56 Million CNY | 195.63% |
| 2008 Q1 | 23.37 Million CNY | 109.41% |
| 2008 Q2 | 19.17 Million CNY | -17.95% |
| 2008 Q3 | 3.53 Million CNY | -81.54% |
| 2008 Q4 | 3.23 Million CNY | -8.56% |
| 2008 FY | - CNY | -5.74% |
| 2007 Q2 | 19.22 Million CNY | -8.04% |
| 2007 FY | - CNY | -11.14% |
| 2007 Q4 | 11.16 Million CNY | -35.05% |
| 2007 Q3 | 17.18 Million CNY | -10.62% |
| 2007 Q1 | 20.9 Million CNY | -13.03% |
| 2006 Q3 | 28.3 Million CNY | 15.63% |
| 2006 Q4 | 24.04 Million CNY | -15.05% |
| 2006 FY | - CNY | 10.39% |
| 2006 Q2 | 24.47 Million CNY | -15.87% |
| 2006 Q1 | 29.09 Million CNY | 27.7% |
| 2005 FY | - CNY | 37.38% |
| 2005 Q3 | 23.65 Million CNY | 0.0% |
| 2005 Q4 | 22.78 Million CNY | -3.68% |
| 2004 FY | - CNY | 60.84% |
| 2003 FY | - CNY | 0.0% |